CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity

BACKGROUND: Cirrhosis is a recognized risk factor for developing hepatocellular carcinoma (HCC). Few studies have reported the expression profile of circRNAs in HCC samples compared to paratumour dysplastic nodule (DN) samples. METHODS: The Arraystar Human circRNA Array combined with laser capture m...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Zhao-Ru, Ke, Ai-Wu, Li, Tao, Cai, Jia-Bing, Yang, Ya-fei, Zhou, Wei, Shi, Guo-Ming, Fan, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117652/
https://www.ncbi.nlm.nih.gov/pubmed/33985545
http://dx.doi.org/10.1186/s12943-021-01361-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117652/
https://www.ncbi.nlm.nih.gov/pubmed/33985545
http://dx.doi.org/10.1186/s12943-021-01361-3

Ejemplares similares